2764 Preliminary results of the phase I/IIa dose finding trial of a folate binding protein vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

J.M Greene,E.J Schneble,J.S Berry,A.F Trappey,G.T Clifton,K Darcy,J.C Elkas,C.A Hamilton,G.L Maxwell,G.E Peoples

doi:10.1016/s0959-8049(16)31530-1

2764 Preliminary results of the phase I/IIa dose finding trial of a folate binding protein vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

J.M Greene, E.J Schneble + Show 8 more

https://doi.org/10.1016/s0959-8049(16)31530-1

Copy DOI

Journal: European Journal of Cancer

Publication Date: Sep 1, 2015

#Ovarian Cancer Patients #Trial Of Vaccine + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

2764 Preliminary results of the phase I/IIa dose finding trial of a folate binding protein vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: European Journal of Cancer

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.